CpG methylation as a basis for breast tumor-specific loss of NES1/kallikrein 10 expression

Cancer Research

Volumn 61, Issue 21, 2001, Pages 8014-8021

  Li, Biao ^a   Goyal, Jaya ^a   Dhar, Sanjay ^a   Dimri, Goberdhan ^a   Evron, Ella ^c,d   Sukumar, Saraswati ^c,d   Wazer, David E ^a   Band, Vimla ^a,b  

^a 4306 CCGC   (United States)

^b TUFTS MEDICAL CENTER   (United States)

^c TUFTS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^d JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOLOGICAL MARKER; BISULFITE; GENE PRODUCT; KALLIKREIN; PROTEIN NES1; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CONTROLLED STUDY; CORRELATION FUNCTION; CPG ISLAND; DIAGNOSTIC VALUE; DISEASE MARKER; GENE EXPRESSION; HUMAN; HUMAN CELL; MOLECULAR CLONING; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN METHYLATION; SEQUENCE ANALYSIS; TRANSCRIPTION REGULATION; TUMOR CELL LINE;

ANTIMETABOLITES, ANTINEOPLASTIC; AZACITIDINE; BREAST NEOPLASMS; CPG ISLANDS; DNA METHYLATION; EXONS; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; INTRONS; KALLIKREINS; LUCIFERASES; PROMOTER REGIONS (GENETICS); RNA, MESSENGER; TUMOR MARKERS, BIOLOGICAL;

EID: 0035503704     PISSN: 00085472     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Loss of p53 protein during radiation transformation of primary human mammary epithelial cells
2. Identification of a novel serine protease-like gene, the expression of which is down-regulated during breast cancer progression
3. Control of enzymatic activity
4. The role for NES1 serine protease as a novel tumor suppressor
5. New nomenclature for the human tissue kallikrein gene family
6. Analysis of NES1/Kallikrein 10 mRNA expression by in situ hybridization, a novel marker for breast cancer
7. Tumor suppressor genes: The puzzle and the promise
8. CpG islands in vertebrate genomes
9. Aberrant patterns of DNA methylation, chromatin formation and gene expression in cancer
10. Cancer epigenetics comes of age
11. 5′ CpG island methylation is associated with transcriptional silencing of the tumor suppressor p16/CDKN2/MTS1 in human cancers
12. High frequency of hypermethylation at the 14-3-3 σ locus leads to gene silencing in breast cancer
13. Methylation and silencing of the retonic acid receptor-β2 gene in breast cancer
14. Loss of cyclin D2 expression in the majority of breast cancers is associated with promoter hypermethylation
15. Changes in DNA methylation in neoplasia: Pathophysiology and therapeutic implications
16. Distinctive traits of normal and tumor-derived human mammary epithelial cells expressed in a medium that supports long-term growth of both cell types
17. Immortalization of distinct human mammary epithelial cell types by human papilloma virus 16 E6 or E7
18. Multiple genetic changes are required for efficient immortalization of different subtypes of normal human mammary epithelial cells
19. Induction of transformation and continuous cell lines from normal human mammary epithelial cells after exposure to benzo[α]pyrene
20. Tumor progression in four mammary epithelial cell lines derived from the same patient
21. Methylation-specific PCR: A novel PCR assay for methylation status of CpG islands
22. Structural characterization and mapping of the normal epithelial cell-specific 1 gene
23. Large-scale human promoter mapping using CpG islands
24. Positive selection of candidate tumor suppressor genes by subtractive hybridization